AG000WIQ

127-58-2 | Benzenesulfonamide, 4-amino-N-(4-methyl-2-pyrimidinyl)-, sodium salt (1:1)

AG000WIQ

SDS

COA

Price

$0.00

Add to Cart

Buy Now

WARNING This product is not for human or veterinary use.

CAS Number	127-58-2
Catalog Number	AG000WIQ(AGN-PC-0PILAY)
Chemical Name	Benzenesulfonamide, 4-amino-N-(4-methyl-2-pyrimidinyl)-, sodium salt (1:1)
EC Number	204-851-0
IUPAC Name	sodium;(4-aminophenyl)sulfonyl-(4-methylpyrimidin-2-yl)azanide
InChI	InChI=1S/C11H11N4O2S.Na/c1-8-6-7-13-11(14-8)15-18(16,17)10-4-2-9(12)3-5-10;/h2-7H,12H2,1H3;/q-1;+1
InChI Key	BSFJGCCAXDCMOX-UHFFFAOYSA-N
MDL Number	MFCD00068332
Molecular Formula	C11H11N4NaO2S
Molecular Weight	286.2854
SMILES	NC1=CC=C(S([N-]C2=NC(C)=CC=N2)(=O)=O)C=C1.[Na+]
UNII	JOV4UJY07O
Synonyms	SULFAMERAZINE SODIUM, 127-58-2, Solumedine, Sulfamerazine sodium salt, Sodium sulfamerazine, Sulfamerazin natrium, Sodium sulphamerazine, Soluble sulfamerazine, UNII-JOV4UJY07O, Sulfamerazine (sodium salt), Solfamerazina sodica [DCIT], 2-Sulfanilamido-4-methylpyrimidine sodium salt, Monosodium 2-sulfanilamido-4-methylpyrimidine, Sulfamerazina sodica [INN-Spanish], Sulfamerazine sodique [INN-French], 4-Methyl-2-sulfanilamidopyrimidine sodium salt, EINECS 204-851-0, Sulfamerazinum natricum [INN-Latin], JOV4UJY07O, NSC 226823, Benzenesulfonamide, 4-amino-N-(4-methyl-2-pyrimidinyl)-, monosodium salt, Sulfamerazine sodium salt monohydrate, Sulfamerazine, sodium salt monohydrate, SULFAMERAZINE SODIUM [INJECTION], N(sup 1)-(4-Methyl-2-pyrimidinyl)sulfanilamide sodium salt, Sodium derivate of N1-(4-methyl-2-pyrimidinyl)sulfanilamide, Sulfanilamide, N(sup 1)-(4-methyl-2-pyrimidinyl)-, monosodium salt, Benzenesulfonamide, 4-amino-N-(4-methyl-2-pyrimidinyl)-, sodium salt (1:1), Solfamerazina sodica, Sulfamerazina sodica, Sulfamerazine sodique, Sulfamerazinum natricum, Sulfamerazine sodium [INN], C11H11N4NaO2S, Sulfamerazine Sodium Injection, Sulfamerazinnatrium, Sulfamerazine sodium Injection [INN], Sulfamerazine sodium [Injection] [INN:NF], Sulfapyridine monosodium salt, C11H11N4O2S.Na, SCHEMBL2820643, CHEMBL2107260, DTXSID1051644, HY-B0512A, 4075AH, AKOS015913915, API0004269, CS-2721, AN-23003, LS-147823, FT-0631742, SR-01000883950, J-005506, SR-01000883950-1, I14-44621, sodium (4-aminophenylsulfonyl)(4-methylpyrimidin-2-yl)amide, sodium (4-aminophenyl)sulfonyl-(4-methylpyrimidin-2-yl)azanide, sodium,(4-aminophenyl)sulfonyl-(4-methylpyrimidin-2-yl)azanide, Sulfanilamide, N1-(4-methyl-2-pyrimidinyl)-, monosodium salt, 4-amino-n-[4-methyl-2-pyrimidinyl]-benzenesulfonamide sodium salt, Benzenesulfonamide, 4-amino-N-(4-methyl-2-pyrimidinyl)-, monosodiumsalt, Sulfanilamide, N1-(4-methyl-2-pyrimidinyl)-, monosodium salt (8CI), Benzenesulfonamide, 4-amino-N-(4-methyl-2-pyrimidinyl)-, monosodium salt (9CI), CID31384, C11-H12-N4-O2-S.Na, Sulfamerazine sodium [Injection:INN], 2-Sulfanilamido-4-methylpyrimidinesodiumsalt, 4-Amino-N-(4-methyl-2-pyrimidinyl)benzenesulfonamide, Bencenosulfonamida, 4-amino-N-(4-metil-2-pirimidinil)-, sal de sodio (1:1),

Complexity	365
Compound Is Canonicalized	Yes
Covalently-Bonded Unit Count	2
Defined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Exact Mass	286.05g/mol
Formal Charge	0
Heavy Atom Count	19
Hydrogen Bond Acceptor Count	6
Hydrogen Bond Donor Count	1
Isotope Atom Count	0
Molecular Weight	286.285g/mol
Monoisotopic Mass	286.05g/mol
Rotatable Bond Count	3
Topological Polar Surface Area	95.3A^2
Undefined Atom Stereocenter Count	0
Undefined Bond Stereocenter Count	0

GHS Hazard and Precautionary Statements

Symbol:
Hazard Class
Hazard statements	H302-H315-H319-H332
Packing Group
Precautionary statements	P305+P351+P338
UN Code

Certificate of Analysis

Lot Number